Abbott Healthcare Products Limited

Mansbridge Road, West End, Southampton, SO18 3JD
Telephone: +44 (0)2380 467 000
Fax: +44 (0)2380 465 350
Medical Information Direct Line: +44 (0)2380 467 000
Medical Information e-mail: medinfo.shl@abbott.com
Medical Information Fax: +44 (0)2380 474518

Patient Information Leaflet last updated on the eMC: 01/02/2012
PIL Colofac IBS

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/02/2012 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to information about pregnancy or lactation
Updated on 06/04/2011 and displayed until 01/02/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Company name change or merger
  • Change to name of manufacturer
Updated on 15/12/2009 and displayed until 06/04/2011
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to dosage and administration
Updated on 08/08/2008 and displayed until 15/12/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 13/03/2000 and displayed until 08/08/2008
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   mebeverine hydrochloride